[{"AccountsPayableCurrent_0_Q1_USD":4989000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":23713000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":6732000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-35776000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4355000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":4602000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":524000.0,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":1004000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":258000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3534000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":4824000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":270000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":344950000.0,"OtherAssetsCurrent_0_Q1_USD":1576000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-27999000.0,"InvestmentIncomeInterest_1_Q1_USD":822000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-5277000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-33276000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":104000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":2213000.0,"LongTermDebtNoncurrent_0_Q1_USD":36209000.0,"OtherExpenses_1_Q1_USD":339000.0,"Goodwill_0_Q1_USD":486000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-943000.0,"LeaseCost_1_Q1_USD":1187000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":78000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":11500000.0,"RestrictedCash_0_Q1_USD":2921000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":900000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-5277000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.1133,"OperatingLeaseRightOfUseAsset_0_Q1_USD":26288000.0,"OperatingLeasePayments_1_Q1_USD":1424000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":30518000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-2645000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5900000.0,"OperatingLeaseCost_1_Q1_USD":1290000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":24051000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4529000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":5449000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":5407000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":5505000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":6001000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":33578000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":60469000.0,"OperatingLeaseLiability_0_Q1_USD":36418000.0,"SubleaseIncome_1_Q1_USD":248000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":1000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":2015000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-2890000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1010000.0,"LiabilitiesNoncurrent_0_Q1_USD":91968000.0,"LiabilitiesCurrent_0_Q1_USD":27128000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":414243000.0,"Liabilities_0_Q1_USD":119096000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-546000.0,"ForeignCurrencyExchangeRateTranslation1_0_Q1_USD\/EUR":1.1,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.63,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-32953000.0,"CostsAndExpenses_1_Q1_USD":35085000.0,"CommonStockSharesOutstanding_0_Q1_shares":44299596.0,"CommonStockSharesIssued_0_Q1_shares":44299596.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":342029000.0,"AssetsNoncurrent_0_Q1_USD":64642000.0,"AssetsCurrent_0_Q1_USD":349601000.0,"Assets_0_Q1_USD":414243000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":13916001.0,"AdditionalPaidInCapital_0_Q1_USD":992136000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-11966000.0,"CommonStockValue_0_Q1_USD":2683000.0,"PrepaidExpenseCurrent_0_Q1_USD":5738000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":677000.0,"ProfitLoss_1_Q1_USD":-27999000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":7211000.0,"OtherIncome_1_Q1_USD":857000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":29800000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":932000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0144,"ShareBasedCompensation_1_Q1_USD":4355000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":9072000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":26013000.0,"OperatingIncomeLoss_1_Q1_USD":-34463000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":1010000.0,"InterestPaidNet_1_Q1_USD":780000.0,"DepreciationAndAmortization_1_Q1_USD":1733000.0,"CommonStockSharesAuthorized_0_Q1_shares":60000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_EUR":0.05,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":9507000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":44279456.0,"StockholdersEquity_0_Q1_USD":295147000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-687706000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":27736000.0,"InterestExpense_1_Q1_USD":975000.0,"VariableLeaseCost_1_Q1_USD":145000.0,"Ticker":"QURE","CIK":"1590560","name":"UNIQURE N.V.","OfficialName":"uniQure N.V. Ordinary Shares","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"814390930.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200429"}]